ArticleCancer research and treatment2026
HER3 Expression and PIK3CA Mutational Status Predict Pathological Response of Neoadjuvant Therapy in HER2-Positive Breast Cancer Patients.
Xi Xia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.